Psychodermatological research priorities identified by Priority Setting Partnerships

Thompson, Andrew R.; Guterres, S.; Bewley, Anthony

doi:10.1111/ced.14447

Cited by 3 publications

(4 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The increasing need to develop and test patient‐centred psychological interventions in dermatology has been the focus of priority setting partnerships for the health service. 37 While traditional ‘face to face’ psychodermatology services are both limited and underdeveloped, there would appear to be some scope for use of psychological interventions that are deployed through m‐Health frameworks. However, in many studies these ‘psychological interventions’ may solely include exercise interventions, educational interventions, and many other types of intervention delivered in an m‐Health format within the catch‐all category of ‘psychologically informed’ interventions.…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study

Fortune

Ravnkilde

Ryan

et al. 2022

Skin Health and Disease

View full text Add to dashboard Cite

Background Despite the psychosocial challenges of living with psoriasis many patients may not be able to access appropriate services to manage these challenges. Mobile health interventions may be helpful as a means to support patients in managing the impact of their condition. Objective To conduct a preliminary examination of the feasibility and acceptability of a bespoke psoriasis‐specific digital therapeutic solution (hereafter termed Allay ), and to provide initial data on psychological changes pre‐post. Methods Phase one proof of concept pre‐post study. Eligible patients were provided with Allay on their smartphone and assessed at baseline and at 12 weeks on a range of indices of well‐being. Participants experiences on usability were collected by telephone interview at 4 weeks, 8 and 12 weeks. Results Out of 66 participants recruited, 59 persisted in using Allay after the familiarisation phase, and 34 participants completed the 12 weeks programme. Participants showed a statistically significant improvement between induction and the end of the 12 weeks programme on Quality of life, Resilience, Perceptions of ‘Overall impact’ of psoriasis, and ‘Emotional impact’. There was a significant change over the course of using Allay for symptoms of depression but not anxiety. While there was an interaction effect of changes in severity of psoriasis symptoms over the course of the study for dermatology‐specific measures, there was no interaction between such changes in psoriasis symptoms and changes in depression, resilience or beliefs in emotional impact. Conclusions Study results suggest that the use of Allay as an adjunct to medical management of psoriasis may help patients improve resilience, mood, beliefs about their condition and enhance their quality of life. Given that this is a phase one proof of concept study, and our rates of attrition further research is necessary to examine comparative effectiveness and stability of these findings.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study

Fortune

Ravnkilde

Ryan

et al. 2022

Skin Health and Disease

View full text Add to dashboard Cite

show abstract

“…Dermatological conditions are associated with elevated rates of mental health problems including mood disorders 1–3 . For many of these conditions, there is a lack of research into the nature and causes of these psychological difficulties, and access to psychological support is severely limited 4 . Mood problems associated with skin conditions may have multiple causes, including stigmatization or bullying, 5 negative impacts upon education, employment or social life, 6 pain/itch, 7 associated sleep problems, 8,9 a need to source and apply medications, 10,11 and comorbid physical ill‐health, 12,13 and such problems can significantly affect patient quality of life (QoL) 14 …”

Section: Introductionmentioning

confidence: 99%

“…[1][2][3] For many of these conditions, there is a lack of research into the nature and causes of these psychological difficulties, and access to psychological support is severely limited. 4 Mood problems associated with skin conditions may have multiple causes, including stigmatization or bullying, 5 negative impacts upon education, employment or social life, 6 pain/itch, 7 associated sleep problems, 8,9 a need to source and apply medications, 10,11 and comorbid physical ill-health, 12,13 and such problems can significantly affect patient quality of life (QoL). 14 Psychodermatological research has often focused on comparing mental health outcomes in specific conditions with those of unaffected controls, using relatively small, clinically ascertained samples originating from a single geographical region, and using a limited range of measures.…”

Section: Introductionmentioning

confidence: 99%

Mood symptoms, neurodevelopmental traits, and their contributory factors in X-linked ichthyosis, ichthyosis vulgaris and psoriasis

Wren

Humby

Thompson

et al. 2022

Clinical and Experimental Dermatology

Self Cite

View full text Add to dashboard Cite

Background. High rates of adverse mood/neurodevelopmental traits are seen in multiple dermatological conditions, and can significantly affect patient quality of life. Understanding the sex-specific nature, magnitude, impact and basis of such traits in lesserstudied conditions like ichthyosis, is important for developing effective interventions. Aim. To quantify and compare relevant psychological traits in men with X-linked ichthyosis (XLI, n = 54) or in XLI carrier women (n = 83) and in patients with ichthyosis vulgaris (IV, men n = 23, women n = 59) or psoriasis (men n = 30, women n = 122), and to identify factors self-reported to contribute most towards depressive, anxious and irritable phenotypes. Methods. Participants recruited via relevant charities or social media completed an online survey of established questionnaires. Data were analysed by sex and skin condition, and compared with general population data. Results. Compared with the general population, there was a higher rate of lifetime prevalence of mood disorder diagnoses across all groups and of neurodevelopmental disorder diagnoses in the XLI groups. The groups exhibited similarly significant elevations in recent mood symptoms (Cohen d statistic 0.95-1.28, P < 0.001) and neurodevelopmental traits (d = 0.31-0.91, P < 0.05) compared with general population controls, and self-reported moderate effects on quality of life and stigmatization. There were strong positive associations between neurodevelopmental traits and recent mood symptoms (r > 0.47, P < 0.01), and between feelings of stigmatization and quality of life, particularly in men. Numerous factors were identified as contributing significantly to mood symptoms in a condition or sex-specific, or condition or sex-independent, manner. Conclusion. We found that individuals with XLI, IV or psoriasis show higher levels of mood disorder diagnoses and symptoms than matched general population controls, and that the prevalence and severity of these is similar across conditions. We also identified a number of factors potentially conferring either general or conditionspecific risk of adverse mood symptoms in the three skin conditions, which could be targeted clinically and/or through education programmes. In clinical practice, recognizing mood/neurodevelopmental problems in ichthyosis and psoriasis, and addressing the predisposing factors identified by this study should benefit the mental health of affected individuals.

show abstract

Psychodermatology in Hungary: Awareness and practice patterns of dermatologists

Cápec,

Jafferany,

Cápec

et al. 2024

Skin Health and Disease

View full text Add to dashboard Cite

BackgroundPsychodermatology is an interdisciplinary branch of medicine between psychiatry /psychology and dermatology.ObjectivesThis study aimed to assess Hungarian dermatologists' awareness, practice patterns and attitudes towards psychodermatology.MethodsA questionnaire‐based survey was sent from October 2020 to June 2021 to 100 dermatologists (including residents in dermatology) in Hungary with a response rate of 51%. The participants were asked about understanding of the concept of psychodermatology and their training in this field, comfort in treatment, and interest in continuing medical education on dermatological disorders with psychological components.Results49% of the respondents understood psychodermatology as a bidirectional interaction of the patient's mental and dermatological conditions, and 25.5% were comfortable in treating psychodermatological patients. The most common dermatological diagnoses with psychological/psychiatric involvement reported were psoriasis and atopic dermatitis. Atopic dermatitis, anxiety, delusional parasitosis, and depression were the most common diagnoses when dermatologists referred patients to psychiatrists. In total, 76.5% of participants could not name any resource (magazine, website, etc.) for patients and their families where information about psychodermatology is available, and 58.8% showed a definite interest in attending training on psychodermatology.ConclusionThe results of our study suggest that Hungarian dermatologists have a high awareness of the term “psychodermatology”, and only a quarter of practitioners feel adequately equipped and comfortable managing patients with psychosomatic aspects in their treatment. The relatively large gap between the number of patients with a psychodermatological component and referrals by dermatologists to mental health specialists indicates the potential importance of more intensive collaboration between dermatologists, psychiatrists and/or psychologists.

show abstract

Psychodermatological research priorities identified by Priority Setting Partnerships

Abstract: Click https://www.wileyhealthlearning.com/ced.aspx for the corresponding questions to this CME article.

Cited by 3 publications

References 5 publications

A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study

A digital therapeutic for management of psychosocial aspects of psoriasis: A pre‐post proof of concept study

Mood symptoms, neurodevelopmental traits, and their contributory factors in X-linked ichthyosis, ichthyosis vulgaris and psoriasis

Psychodermatology in Hungary: Awareness and practice patterns of dermatologists

Contact Info

Product

Resources

About